The Flow Cytometry Facility has supported UWCCC investigators since 1988. It includes laboratories at two sites. The main laboratory is located at the Clinical Science Center (CSC) and remodeling for a satellite laboratory that will be located on the central campus at the McArdle Laboratory will be completed in Fall 2006. The Facility is staffed from 8:00 AM until 5:00 PM Monday through Friday, but the technologies are available to trained users at all times. The laboratory staff maintain all instruments and provide support for data acquisition;sorting;instruction in performing data analysis, instruction on instrument operation, consultation on experimental design, sample handling, and staining protocols;education on basic principles of flow cytometry through seminars, lab meetings, or course work, as well as a series of three lectures for beginners offered monthly;on-site staining facilities;and sample preparation and analysis of specimens submitted from clinical trials. This service is also available to clinicians without research laboratories who are conducting clinical trials. (The facility is dedicated to research and does not perform routine clinical analyses used in patient diagnosis and treatment.) The Facility manages and operates the following equipment: two high-speed sorters, FACScan, FACSCalibur, LSR, Pathway Biolmager, off-line computers for data analysis, and an Olympus Fluorescence Microscope. Through support of the Cancer Center Support Grant coupled with a significant on-going investment by the Cancer Center with institutional funds and philanthropic funds, as well as support from successful instrumentation grants, this facility provides the latest cutting-edge technology to UWCCC members.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Center Core Grants (P30)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Wisconsin Madison
United States
Zip Code
Zaitoun, Ismail S; Cikla, Ulas; Zafer, Dila et al. (2018) Attenuation of Retinal Vascular Development in Neonatal Mice Subjected to Hypoxic-Ischemic Encephalopathy. Sci Rep 8:9166
Hart, Vicki; Trentham-Dietz, Amy; Berkman, Amy et al. (2018) The association between post-diagnosis health behaviors and long-term quality of life in survivors of ductal carcinoma in situ: a population-based longitudinal cohort study. Qual Life Res 27:1237-1247
Lee, Hye Jin; Ehlerding, Emily B; Cai, Weibo (2018) Antibody-Based Tracers for PET/SPECT Imaging of Chronic Inflammatory Diseases. Chembiochem :
Elsaid, Mohamed Y; Shahi, Ankita; Wang, Albert R et al. (2018) Enhanced Radiosensitivity in Solid Tumors using a Tumor-selective Alkyl Phospholipid Ether Analog. Mol Cancer Ther 17:2320-2328
Dennison, Kirsten L; Chack, Aaron C; Hickman, Maureen Peters et al. (2018) Ept7, a quantitative trait locus that controls estrogen-induced pituitary lactotroph hyperplasia in rat, is orthologous to a locus in humans that has been associated with numerous cancer types and common diseases. PLoS One 13:e0204727
Jamali, Nasim; Sorenson, Christine M; Sheibani, Nader (2018) Vitamin D and regulation of vascular cell function. Am J Physiol Heart Circ Physiol 314:H753-H765
Liu, Zhen; Ehlerding, Emily B; Cai, Weibo et al. (2018) One-step synthesis of an 18F-labeled boron-derived methionine analog: a substitute for 11C-methionine? Eur J Nucl Med Mol Imaging 45:582-584
Chakravarty, Rubel; Siamof, Cerise M; Dash, Ashutosh et al. (2018) Targeted ?-therapy of prostate cancer using radiolabeled PSMA inhibitors: a game changer in nuclear medicine. Am J Nucl Med Mol Imaging 8:247-267
Albertini, Mark R; Yang, Richard K; Ranheim, Erik A et al. (2018) Pilot trial of the hu14.18-IL2 immunocytokine in patients with completely resectable recurrent stage III or stage IV melanoma. Cancer Immunol Immunother 67:1647-1658
Saghiri, Mohammad Ali; Asatourian, Armen; Nguyen, Eric H et al. (2018) Hydrogel Arrays and Choroidal Neovascularization Models for Evaluation of Angiogenic Activity of Vital Pulp Therapy Biomaterials. J Endod 44:773-779

Showing the most recent 10 out of 1528 publications